Volume 17, Number 12—December 2011
Research
Hepatitis E Virus in Rats, Los Angeles, California, USA
Table 1
Inoculum |
Genotype |
ID50 |
No. injected |
No. with HEV RNA or antibodies against HEV |
Sar 55 | 1 | 103.8† | 2 | 0 |
Akluj-90 | 1 | 104.8† | 2 | 0 |
Kashi-87 | 1 | 108.1‡ | 2 | 0 |
Mex14 | 2 | 104.3† | 4 | 0 |
Meng | 3 | 104.3§ | 4 | 0 |
Meng | 3 | 102.3¶ | 4 | 0 |
*HEV, hepatitis E virus. The 50% infectious dose (ID50) was administered intravenously.
†In human feces and titered in macaques.
‡Quantitative reverse transcription PCR titer.
§In pig feces and titered in pigs.
¶In macaque feces and titered in macaques.
1Current affiliation: Embassy of France, Beijing, People’s Republic of China.
2Current affiliation: National Institutes of Health, Frederick, Maryland, USA.
Page created: November 30, 2011
Page updated: November 30, 2011
Page reviewed: November 30, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.